Tag: Health Care

hovione
Europe

Hovione strengthens its global position as a top employer for the third consecutive year

Hovione has once again solidified its position as a top employer. Press Release – Jan 16, 2025 Lisbon, January 16, 2025 – Hovione, an international integrated pharmaceutical development and manufacturing organization, has once again solidified its position as a top employer. For the third consecutive year, all four of its manufacturing sites – Lisbon (Portugal), Cork (Ireland), East Windsor (NJ, USA), and Macau – have been … Continue reading Hovione strengthens its global position as a top employer for the third consecutive year

Impact Newswire
JOHNSON & JOHNSON
United States

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults sNDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has potential to become a standard of care for most common depressive disorders CAPLYTA® adds to Johnson & Johnson’s robust lineup of … Continue reading Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Impact Newswire
Hippocratic AI
United States

Hippocratic AI Launches AI Agent App Store for Healthcare

Empowering Clinicians to Extend Their Impact and Earn Through Innovation Press Release – January 09, 2025 – PALO ALTO, Calif. – Hippocratic AI, the company that pioneered the first healthcare LLM for patient-facing non-diagnostic clinical tasks, today announced the launch of its Healthcare AI Agent App Store.Marking a bold step forward in healthcare innovation, the AI Agent App Store empowers clinicians to design and shape artificial … Continue reading Hippocratic AI Launches AI Agent App Store for Healthcare

Impact Newswire
AI EVERYTHING GLOBAL 2025
Global, Middle East

AI EVERYTHING GLOBAL – REGISTRATION IS LIVE!

Brace yourself for three extraordinary days across Abu Dhabi and Dubai at the world’s largest AI community gathering!  With an exclusive Summit for global leaders in Abu Dhabi and a thrilling exhibition showcase in Dubai, Ai Everything GLOBAL 2025 brings the best of the AI world to UAE. Be part of the legacy. Secure your pass NOW! – Click Here 📍 4 Feb 2025: Summit … Continue reading AI EVERYTHING GLOBAL – REGISTRATION IS LIVE!

Impact Newswire
VMG Health
United States

VMG Health Acquires Veralon®, Healthcare Consulting Firm

Press Release – January 07, 2025 – BALA CYNWYD, Pa. – VMG Health is pleased to announce its acquisition of Veralon, a national leader in healthcare strategy, finance, valuation, provider compensation, and virtual board education. This strategic move reinforces VMG Health’s position as the premier consultancy dedicated to helping healthcare organizations across the nation achieve and sustain superior business performance. VMG Health is a portfolio company of Incline … Continue reading VMG Health Acquires Veralon®, Healthcare Consulting Firm

Impact Newswire
Maurice van Tilburg
Europe

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Current Renovaro Chairman to Lead Subsidiary’s Development Program and Commercialization Los Angeles and Amsterdam – December 30, 2024 – Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced Chairman of the Board, Maurice van Tilburg, has been appointed as Chief Executive Officer of its subsidiary GEDi Cube BV (a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies) DBA RenovaroCube. … Continue reading Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Impact Newswire
Marinus
United States

Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.

Press Release – STOCKHOLM & RADNOR, Pa. – Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today announced that they have entered into an agreement and plan of merger under which Immedica has agreed to acquire Marinus, by means of a tender offer and subsequent merger. … Continue reading Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.

Impact Newswire
vincerx
United States

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined company’s pipeline PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a … Continue reading Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Impact Newswire
Diversified Healthcare Trust
United States

Diversified Healthcare Trust Appoints Anthony Paula as Vice President

Press Release – December 18, 2024 – NEWTON, Mass. – Diversified Healthcare Trust (Nasdaq: DHC) today announced that Anthony Paula has been appointed Vice President. Mr. Paula is a Vice President of The RMR Group (Nasdaq: RMR), whose responsibilities include overseeing the accounting, SEC reporting and corporate finance functions for DHC. Mr. Paula has more than 15 years of real estate experience, including accounting and corporate finance, … Continue reading Diversified Healthcare Trust Appoints Anthony Paula as Vice President

Impact Newswire